US2012108623A1PendingUtilityA1

Beloxepin and analogs for the treatment of pain

50
Assignee: LE BOURDONNEC BERTRANDPriority: Feb 19, 2008Filed: Oct 4, 2011Published: May 3, 2012
Est. expiryFeb 19, 2028(~1.6 yrs left)· nominal 20-yr term from priority
Inventors:Bertrand Le BourdonnecRoland E. Dolle
A61P 29/00A61K 31/4353A61P 25/00
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This present disclosure provides methods of treating pain with beloxepin and/or beloxepin analogs.

Claims

exact text as granted — not AI-modified
1 . A method of treating pain in a mammal, comprising administering to a mammal suffering from pain an amount of beloxepin, or a salt thereof, effective to treat the pain. 
     
     
         2 . The method of  claim 1  in which the beloxepin is administered parenterally. 
     
     
         3 . The method of  claim 1  in which the beloxepin is administered orally. 
     
     
         4 . The method of  claim 1  in which the pain is acute or chronic pain of nociceptive origin. 
     
     
         5 . The method of  claim 4  in which the pain is inflammatory pain. 
     
     
         6 . The method of  claim 4  in which the pain is cancer pain. 
     
     
         7 . The method of  claim 1  in which the pain is chronic pain of non-nociceptive origin. 
     
     
         8 . The method of  claim 7  in which the pain is neuropathic pain. 
     
     
         9 . The method of  claim 1  in which the pain is visceral pain. 
     
     
         10 . The method of any one of  claims 1 - 9  in which the mammal is a human. 
     
     
         11 . A method of treating pain in a mammal, comprising administering to a mammal suffering from pain an amount of beloxepin and/or a beloxepin analog, or a salt thereof, effective to treat the pain. 
     
     
         12 . The method of  claim 11  in which the pain is acute or chronic pain of nociceptive origin. 
     
     
         13 . The method of  claim 12  in which the pain is inflammatory pain. 
     
     
         14 . The method of  claim 12  in which the pain is cancer pain. 
     
     
         15 . The method of  claim 11  in which the pain is chronic pain of non-nociceptive origin. 
     
     
         16 . The method of  claim 15  in which the pain is neuropathic pain. 
     
     
         17 . The method of  claim 11  in which the pain is visceral pain. 
     
     
         18 . The method of any one of  claims 11 - 17  in which the beloxepin, beloxepin analog and/or a salt thereof, is administered to the mammal in the form of a composition. 
     
     
         19 . The method of  claim 18  in which the beloxepin and/or beloxepin analog is included in the composition as a salt. 
     
     
         20 . The method of  claim 18  in which the mammal is a human. 
     
     
         21 . The method of  claim 18  in which the composition is formulated for oral administration 
     
     
         22 . The method of  claim 21  in which the mammal is a human.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.